Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 and CCR5

2018/29/N/NZ7/00287

Keywords:

pain neuropathy chemokines CCR2 CCR5 pharmacotherapy maraviroc RS504393 cenicriviroc bindarit opioids

Descriptors:

  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Klaudia Kwiatkowski 

Number of co-investigators in the project: 3

Call: PRELUDIUM 15 - announced on 2018-03-15

Amount awarded: 209 900 PLN

Project start date (Y-m-d): 2019-02-06

Project end date (Y-m-d): 2023-02-05

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Aparat Mini-PROTEAN do poczwórnej pionowej elektroforezy (2 600 PLN)
  2. Aparat do elektroforezy z wykorzystaniem żeli Criterion (2 700 PLN)
  3. Ogranicznik dla gryzoni z oświetlaczem ogona do podań dożylnych (4 114 PLN)

Information in the final report

  • Publication in academic press/journals (3)
  • Articles in post-conference publications (4)
  1. Bidirectional action of cenicriviroc, a CCR2/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy.
    Authors:
    Kwiatkowski K., Pawlik K., Ciapała K., Piotrowska A., Makuch W., Mika J.
    Academic press:
    Front. Immunol. (rok: 2020, tom: 11, strony: 615327(1-16)), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2020.615327 - link to the publication
  2. Pharmacological Evidence of the Important Roles of CCR1 and CCR3 and Their Endogenous Ligands CCL2/7/8 in Hypersensitivity Based on a Murine Model of Neuropathic Pain.
    Authors:
    Pawlik K, Ciapała K, Ciechanowska A, Kwiatkowski K, Mika J.
    Academic press:
    Cells (rok: 2023, tom: 12, strony: 98), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cells12010098 - link to the publication
  3. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses.
    Authors:
    Kwiatkowski K. Ciapała K., Rojewska E., Makuch W., Mika J.
    Academic press:
    Int Immunopharmacol. (rok: 2020, tom: 84, strony: 106540 (1-12)), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.intimp.2020.106540. - link to the publication
  1. Czy leki antyretrowirusowe mogą działać przeciwbólowo? Rola CCR5 w bólu neuropatycznym.
    Authors:
    Kwiatkowski K., Ciapała K., Popiolek-Barczyk K., Piotrowska A., Makuch W., Mika J.
    Conference:
    X Zjazd Polskiego Towarzystwa Badania Bólu – MEDYCYNA BÓLU 2019 (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 2019-09-26-28
    Status:
    Published
  2. The dual CCR2/CCR5 antagonist, Cenicriviroc, attenuated neuropathic pain-related behavior and enhanced morphine effectiveness.
    Authors:
    Ciapała K., Kwiatkowski K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 2019-09-4-7
    Status:
    Published
  3. Involvement of chemokines CCL2 and CCL7 in pathogenesis of neuropathic pain in mice.
    Authors:
    Kwiatkowski K., Popiolek-Barczyk K., Rojewska E., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 2019-06-22-27
    Status:
    Published
  4. Comparison of analgesic effects of maraviroc, RS504393 and cenicriviroc in rodents after sciatic nerve injury based on behavioral and molecular studies.
    Authors:
    Kwiatkowski K., Ciapała K., Popiołek-Barczyk K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 2019-09-4-7
    Status:
    Published